Cerus Employee Directory
Biotechnology ResearchCalifornia, United States201-500 Employees
Cerus Corporation focuses on safeguarding the world's blood supply by developing technologies and blood components designed to reduce pathogen transmission. Headquartered in Concord, California, it serves blood centers, hospitals, and patients who rely on safe blood products. Its INTERCEPT Blood System for platelets and plasma is available globally and holds CE mark and FDA approval for these components, while the INTERCEPT Fibrinogen Complex is approved in the US for pathogen-reduced cryoprecipitated fibrinogen. The red blood cell system is in late-stage clinical development. A notable recent development is a four-year supply agreement with Établissement Français du Sang for the INTERCEPT Blood System, including the LED-based INT200 device, illustrating ongoing collaboration with national blood services.
1-888-653-2347 
support@leadiq.com 
